|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
1396596 |
003 |
ICU |
005 |
19970808001500.0 |
008 |
921203s1992 nyua b 001 0 eng |
010 |
|
|
|a 91004436
|
020 |
|
|
|a 0716770091
|
035 |
|
|
|a (ICU)BID16407757
|
035 |
|
|
|a (OCoLC)23080569
|
040 |
|
|
|c DLC
|d DLC$dOrLoB
|
050 |
0 |
0 |
|a QP552.P4
|b S963 1992
|
082 |
|
|
|a 547.7/56
|2 20
|
245 |
0 |
0 |
|a Synthetic peptides :
|b a user's guide /
|c edited by Gregory A. Grant.
|
260 |
|
|
|a New York :
|b W.H. Freeman,
|c c1992.
|
300 |
|
|
|a xii, 382 p. :
|b ill. ;
|c 23 cm.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
440 |
|
0 |
|a UWBC biotechnical resource series
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
0 |
|g 1.
|t Overview.
|t Synthetic Peptides: Spanning the Twentieth Century --
|g 2.
|t Peptide Design Considerations.
|t Protein and Amino Acid Chemistry.
|t Protein Structure.
|t Application of Sequence Analysis to Modeling and Design.
|t Other Aspects of Peptide Design --
|g 3.
|t Principles and Practice of Solid-Phase Peptide Synthesis.
|t Overview of Solid-Phase Strategy.
|t Protection Schemes.
|t Polymeric Support.
|t Attachment to Support.
|t Formation of Peptide Bond.
|t Monitoring.
|t Automation of Solid-Phase Synthesis.
|t Cleavage.
|t Post-translational Modifications and Unnatural Structures.
|t Auxiliary Issues --
|g 4.
|t Evaluation of the Finished Product.
|t General Considerations.
|t Initial Indicators of Quality.
|t Purification.
|t Detailed Characterization of Covalent Structure.
|t An Example of the Complete Evaluation of a Synthetic Peptide from Crude Product to Homogeneous Peptide.
|t Storage and Handling of Synthetic Peptides.
|t How Much Is Enough? --
|g 5.
|t Applications of Synthetic Peptides.
|t Antigenic and Immunogenic Uses of Synthetic Peptides.
|t Use of Peptides as Enzyme Inhibitors.
|t Structure-Function Studies.
|t Peptide-Based Vaccines.
|t Antisense Peptides.
|t The Use of Peptides for Affinity Labeling of Receptors.
|t Receptor Studies--A Brief Overview of Structure-Activity Relationship --
|g 6.
|t Setup of a Core Facility.
|t An Institutional Core Laboratory.
|t A Small, Shared Peptide Synthesis Laboratory.
|
650 |
|
0 |
|a Peptides
|x Synthesis
|0 http://id.loc.gov/authorities/subjects/sh85099691
|
650 |
|
0 |
|a Protein engineering
|0 http://id.loc.gov/authorities/subjects/sh86007375
|
650 |
|
7 |
|a Peptides
|x Synthesis.
|2 fast
|0 http://id.worldcat.org/fast/fst01057580
|
650 |
|
7 |
|a Protein engineering.
|2 fast
|0 http://id.worldcat.org/fast/fst01079685
|
700 |
1 |
0 |
|a Grant, Gregory A.,
|d 1949-
|0 http://id.loc.gov/authorities/names/n91005175
|1 http://viaf.org/viaf/112985888
|
850 |
|
|
|a ICU
|
901 |
|
|
|a ToCBNA
|
903 |
|
|
|a HeVa
|
929 |
|
|
|a cat
|
999 |
f |
f |
|i 5b5ca81d-02e2-5407-ab53-c223aeeb3515
|s f90fed35-62e3-5d1a-bffc-52d106709b4b
|
928 |
|
|
|t Library of Congress classification
|a QP552.P4S9630 1992
|l JCL
|c JCL-Sci
|i 2730639
|
927 |
|
|
|t Library of Congress classification
|a QP552.P4S9630 1992
|l JCL
|c JCL-Sci
|e CRERAR
|b 38492812
|i 2757047
|